Age and severity of nigrostriatal damage at onset of Parkinson's disease
Identifieur interne : 001808 ( Main/Exploration ); précédent : 001807; suivant : 001809Age and severity of nigrostriatal damage at onset of Parkinson's disease
Auteurs : Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]Source :
- Synapse [ 0887-4476 ] ; 2003-02.
English descriptors
Abstract
The clinical evolution of Parkinson's disease (PD) is known to be partly dependent on the age of onset. For example, motor complications associated with chronic dopaminomimetic treatment occur more often in younger patients. However, few attempts have been made to characterize the functional pathological differences underlying this age effect. We investigated the relationship between age and severity of nigrostriatal damage at onset of PD. Twenty patients with early PD (symptom duration ≤5 years) with onset before age 50 (n = 10) and with onset after age 50 (n = 10) were studied. The two groups were compared with respect to severity of nigrostriatal damage as evaluated by positron emission tomography (PET) scanning with 6‐[18F]fluoro‐L‐dopa ([18F]‐dopa), (±)‐α‐[11C]dihydrotetrabenazine ([11C]DTBZ), and d‐threo‐[11C]methylphenidate ([11C]MP). We found no significant differences between younger‐ and older‐onset PD patients with regard to any of the three presynaptic markers. For putamen, the P‐values corresponding to the different PET measurements ranged from P = 0.34 ([18F]‐dopa) to P = 0.79 ([11C]DTBZ). However, after adjusting for treatment and PD duration, regression analysis showed that [18F]‐dopa uptake correlated positively with age of onset (r = 0.59; P = 0.010). No correlation was found between [11C]DTBZ and [11C]MP binding potentials and age of onset (P = 0.26 and P = 0.90, respectively). These data suggest that age‐of‐onset‐dependent differences in clinical evolution are not likely to reflect early differences in nigrostriatal pathology in PD. Age‐related differences in [18F]‐dopa uptake may be related to changes in dopamine turnover. Synapse 47:152–158, 2003. © 2002 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/syn.10160
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Age and severity of nigrostriatal damage at onset of Parkinson's disease</title><author><name sortKey="De La Fuente Ernandez, Raul" sort="De La Fuente Ernandez, Raul" uniqKey="De La Fuente Ernandez R" first="Raúl" last="De La Fuente-Fernández">Raúl De La Fuente-Fernández</name></author><author><name sortKey="Lim, Andrew S" sort="Lim, Andrew S" uniqKey="Lim A" first="Andrew S." last="Lim">Andrew S. Lim</name></author><author><name sortKey="Sossi, Vesna" sort="Sossi, Vesna" uniqKey="Sossi V" first="Vesna" last="Sossi">Vesna Sossi</name></author><author><name sortKey="Adam, Michael J" sort="Adam, Michael J" uniqKey="Adam M" first="Michael J." last="Adam">Michael J. Adam</name></author><author><name sortKey="Ruth, Thomas J" sort="Ruth, Thomas J" uniqKey="Ruth T" first="Thomas J." last="Ruth">Thomas J. Ruth</name></author><author><name sortKey="Calne, Donald B" sort="Calne, Donald B" uniqKey="Calne D" first="Donald B." last="Calne">Donald B. Calne</name></author><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></author><author><name sortKey="Lee, Chong S" sort="Lee, Chong S" uniqKey="Lee C" first="Chong S." last="Lee">Chong S. Lee</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B52CE4E588FCA7326DC0ACECC3C3D87F73FE5D6C</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/syn.10160</idno><idno type="url">https://api.istex.fr/document/B52CE4E588FCA7326DC0ACECC3C3D87F73FE5D6C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000E15</idno><idno type="wicri:Area/Main/Curation">000C48</idno><idno type="wicri:Area/Main/Exploration">001808</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Age and severity of nigrostriatal damage at onset of Parkinson's disease</title><author><name sortKey="De La Fuente Ernandez, Raul" sort="De La Fuente Ernandez, Raul" uniqKey="De La Fuente Ernandez R" first="Raúl" last="De La Fuente-Fernández">Raúl De La Fuente-Fernández</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author><author><name sortKey="Lim, Andrew S" sort="Lim, Andrew S" uniqKey="Lim A" first="Andrew S." last="Lim">Andrew S. Lim</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author><author><name sortKey="Sossi, Vesna" sort="Sossi, Vesna" uniqKey="Sossi V" first="Vesna" last="Sossi">Vesna Sossi</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author><author><name sortKey="Adam, Michael J" sort="Adam, Michael J" uniqKey="Adam M" first="Michael J." last="Adam">Michael J. Adam</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author><author><name sortKey="Ruth, Thomas J" sort="Ruth, Thomas J" uniqKey="Ruth T" first="Thomas J." last="Ruth">Thomas J. Ruth</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author><author><name sortKey="Calne, Donald B" sort="Calne, Donald B" uniqKey="Calne D" first="Donald B." last="Calne">Donald B. Calne</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author><author><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author><author><name sortKey="Lee, Chong S" sort="Lee, Chong S" uniqKey="Lee C" first="Chong S." last="Lee">Chong S. Lee</name><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Pacific Parkinson's Research Centre, and TRIUMF, University of British Columbia, Vancouver, B.C.</wicri:regionArea><wicri:noRegion>B.C.</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Synapse</title><title level="j" type="abbrev">Synapse</title><idno type="ISSN">0887-4476</idno><idno type="eISSN">1098-2396</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2003-02">2003-02</date><biblScope unit="volume">47</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="152">152</biblScope><biblScope unit="page" to="158">158</biblScope></imprint><idno type="ISSN">0887-4476</idno></series><idno type="istex">B52CE4E588FCA7326DC0ACECC3C3D87F73FE5D6C</idno><idno type="DOI">10.1002/syn.10160</idno><idno type="ArticleID">SYN10160</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0887-4476</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>PET</term><term>[11C]dihydrotetrabenazine</term><term>[11C]methylphenidate</term><term>[18F]fluorodopa</term><term>fluctuations</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The clinical evolution of Parkinson's disease (PD) is known to be partly dependent on the age of onset. For example, motor complications associated with chronic dopaminomimetic treatment occur more often in younger patients. However, few attempts have been made to characterize the functional pathological differences underlying this age effect. We investigated the relationship between age and severity of nigrostriatal damage at onset of PD. Twenty patients with early PD (symptom duration ≤5 years) with onset before age 50 (n = 10) and with onset after age 50 (n = 10) were studied. The two groups were compared with respect to severity of nigrostriatal damage as evaluated by positron emission tomography (PET) scanning with 6‐[18F]fluoro‐L‐dopa ([18F]‐dopa), (±)‐α‐[11C]dihydrotetrabenazine ([11C]DTBZ), and d‐threo‐[11C]methylphenidate ([11C]MP). We found no significant differences between younger‐ and older‐onset PD patients with regard to any of the three presynaptic markers. For putamen, the P‐values corresponding to the different PET measurements ranged from P = 0.34 ([18F]‐dopa) to P = 0.79 ([11C]DTBZ). However, after adjusting for treatment and PD duration, regression analysis showed that [18F]‐dopa uptake correlated positively with age of onset (r = 0.59; P = 0.010). No correlation was found between [11C]DTBZ and [11C]MP binding potentials and age of onset (P = 0.26 and P = 0.90, respectively). These data suggest that age‐of‐onset‐dependent differences in clinical evolution are not likely to reflect early differences in nigrostriatal pathology in PD. Age‐related differences in [18F]‐dopa uptake may be related to changes in dopamine turnover. Synapse 47:152–158, 2003. © 2002 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="De La Fuente Ernandez, Raul" sort="De La Fuente Ernandez, Raul" uniqKey="De La Fuente Ernandez R" first="Raúl" last="De La Fuente-Fernández">Raúl De La Fuente-Fernández</name></noRegion><name sortKey="Adam, Michael J" sort="Adam, Michael J" uniqKey="Adam M" first="Michael J." last="Adam">Michael J. Adam</name><name sortKey="Calne, Donald B" sort="Calne, Donald B" uniqKey="Calne D" first="Donald B." last="Calne">Donald B. Calne</name><name sortKey="Lee, Chong S" sort="Lee, Chong S" uniqKey="Lee C" first="Chong S." last="Lee">Chong S. Lee</name><name sortKey="Lim, Andrew S" sort="Lim, Andrew S" uniqKey="Lim A" first="Andrew S." last="Lim">Andrew S. Lim</name><name sortKey="Ruth, Thomas J" sort="Ruth, Thomas J" uniqKey="Ruth T" first="Thomas J." last="Ruth">Thomas J. Ruth</name><name sortKey="Sossi, Vesna" sort="Sossi, Vesna" uniqKey="Sossi V" first="Vesna" last="Sossi">Vesna Sossi</name><name sortKey="Stoessl, A Jon" sort="Stoessl, A Jon" uniqKey="Stoessl A" first="A. Jon" last="Stoessl">A. Jon Stoessl</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001808 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001808 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B52CE4E588FCA7326DC0ACECC3C3D87F73FE5D6C
|texte= Age and severity of nigrostriatal damage at onset of Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |